For the last couple of weeks, I've had the "2000" portfolio showing for this thread. Despite sitting largely in cash for most of the year (since KDUS popped, currently $199K cash of $378K value), it's up 278% for the year (spectacular for any other sector or any other year, but nothing special in light of events).
However, it has not been actively managed. I'll keep it around, but I'm substituting a new portfolio for attachment to the thread. As always, the start is $100K. This time, however, I'm not including commissions. Since I've never followed through, long-term, with the portfolios, it's silly for me to make "real world" accommodations.
The new portfolio is "TRICKLE".
The intent is to find bargains among those companies that provide instrumentation, equipment, reagents, etc. The rationale is the prolonged flood of liquidity which has hit the sector.
I've only added three components, KDUS, NBSC and MDCC. Unlike situations in the past, where I've mobilized only a little cash and solicited suggestions for portfolio components, I've invested all of the money. Nonetheless, I am again soliciting suggestions, and I'll sell stuff to integrate them.
Rationale....
NBSC: undervalued, DGI kicker
KDUS: undervalued, play on Axiom and Biacore interest
MDCC: began consolidation (LJLB) at the correct time, IMO
Again, I would appreciate suggestions for additional components. I feel, in general, that reagents have been sexy and somewhat over valued for some time (convincing me that "a BIOI" is wise will take some effort). Will be glad to entertain suggestions re. leveraged plays or hidden gems, however. |
